Th17 and regulatory T cells contribute to the in situ immune response in skin lesions of Jorge Lobo's disease

Carregando...
Imagem de Miniatura
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2016
Editora
OXFORD UNIV PRESS
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
BARBOZA, Tania Cristina
BRITO, Arival Cardoso de
XAVIER, Marilia Brasil
OLIVEIRA, Clivia Maria Moraes de
UNGER, Deborah Aben Athar
QUARESMA, Juarez Antonio Simoes
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
MEDICAL MYCOLOGY, v.54, n.1, p.23-28, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Jorge Lobo's disease (JLD) is a chronic granulomatous mycosis described in various Latin American countries. The main objective of the present study was to investigate the possible role of Th17 and Foxp3+ Treg cells in the pathogenesis of Jorge Lobo's disease. Human skin biopsies were submitted to an immunohistochemistry protocol to detect Foxp3, interleukin (IL)-1beta, CD25, IL-6, IL-17, and IL-23. The epidermis presented acanthosis, hyperkeratosis, and frequent presence of fungi. The dermis presented inflammatory infiltrate comprising macrophages, lymphocytes, epithelioid and multinucleated cells, and an intense number of fungi. Foxp3+ Treg cells and IL-17+ cells were visualized in lymphocytes in the inflammatory infiltrate. IL-1, IL-2R (CD25), IL-6, and IL-23 were visualized in the dermis, intermingled with fungal cells, permeating or participating of the granuloma. Following IL-17, the most prominent cytokine was IL-6. IL-23 and cells expressing CD25 were present in fewer number. The comparative analysis between IL-17 and Foxp3 demonstrated a statistically significant increased number of IL-17+ cells. Th17 cells play a role in the immune response of JLD. IL-1beta and IL-6 added to the previously described increased number of TGF-beta would stimulate such pattern of response. Th17 cells could be present as an effort to modulate the local immune response; however, high levels of a Th17 profile could overcome the role of Treg cells. The unbalance between Treg/Th17 cells seems to corroborate with the less effective immune response against the fungus.
Palavras-chave
Jorge Lobo's Disease, immune response, Th17 cells, regulatory T cells
Referências
  1. Mercer F, 2014, J IMMUNOL, V193, P1047, DOI 10.4049/jimmunol.1302936
  2. Quaresma JAS, 2010, ACTA TROP, V114, P59, DOI 10.1016/j.actatropica.2009.12.005
  3. Xavier MB, 2008, HUM PATHOL, V39, P269, DOI 10.1016/j.humpath.2007.06.016
  4. FUCHS J, 1990, CUTIS, V46, P227
  5. Woods WJ, 2010, REV INST MED TROP SP, V52, P273, DOI 10.1590/S0036-46652010000500010
  6. Opromolla DVA, 2003, INT J DERMATOL, V42, P938, DOI 10.1111/j.1365-4632.2003.01982.x
  7. Yang Y, 2008, J IMMUNOL, V181, P8700
  8. Hernandez-Santos N, 2012, CELL HOST MICROBE, V11, P425, DOI 10.1016/j.chom.2012.04.008
  9. Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610
  10. Taborda PR, 1999, J CLIN MICROBIOL, V37, P2031
  11. Pagliari C, 2011, MICROB PATHOGENESIS, V50, P263, DOI 10.1016/j.micpath.2010.12.008
  12. Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005
  13. Vautier S, 2010, CYTOKINE GROWTH F R, V21, P405, DOI 10.1016/j.cytogfr.2010.10.001
  14. Vilani-Moreno FR, 2011, MED MYCOL, V49, P643, DOI 10.3109/13693786.2010.547993
  15. Ghilardi N, 2007, SEMIN IMMUNOL, V19, P383, DOI 10.1016/j.smim.2007.10.016
  16. Marcos EVC, 2005, REV SOC BRAS MED TRO, V38, P399, DOI 10.1590/S0037-86822005000500007
  17. Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200
  18. McGeachy MJ, 2007, SEMIN IMMUNOL, V19, P372, DOI 10.1016/j.smim.2007.10.012
  19. Baruzzi R G, 1979, Rev Inst Med Trop Sao Paulo, V21, P303
  20. Brito A. C. de, 2007, Anais Brasileiros de Dermatologia, V82, P461, DOI 10.1590/S0365-05962007000500010
  21. Carneiro FRO, 2015, HUM PATHOL, V46, P334, DOI 10.1016/j.humpath.2014.10.016
  22. Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102
  23. Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152
  24. Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754
  25. Opromolla DVA, 2005, DINAMICA DOENCAS INF, P1185
  26. Opromolla D. V. A., 1999, Anais Brasileiros de Dermatologia, V74, P345
  27. Opromolla D. V. A., 1999, Anais Brasileiros de Dermatologia, V74, P135
  28. Pradinaud R, 1996, ENCYCL MED CHIR, P1
  29. Silva AAD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003162
  30. Vilani-Moreno F. R., 1997, Anais Brasileiros de Dermatologia, V72, P433